发明名称 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE
摘要 Provided is a novel JAK3 inhibitor useful as a preventive and/or therapeutic agent for preventing and/or treating rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjogren's syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic conjunctivitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia, etc. A pyridine-3-carboxyamide derivative represented by general formula (1)or a salt thereof or a solvate thereof.
申请公布号 EA021367(B1) 申请公布日期 2015.06.30
申请号 EA20110000860 申请日期 2009.11.27
申请人 KOWA COMPANY, LTD. 发明人 KITAMURA TAKAHIRO;YAMADA HAJIME;TAKEMURA SHUNJI;ASHIKAWA MASANORI;ISHIKAWA TETSUYA;MIYAKE YOSHIHARU;KOUKETSU AKIYASU;SATO SEIICHI;ISHIWATA HIROYUKI;TABUNOKI YUICHIRO;SHIBASAKI MANABU;OZAWA TAKATOSHI;SHIGEMI RYOTA;DOI TAKESHI;TAMURA MASAHIRO
分类号 C07D213/82;A61K31/44;A61K31/4439;A61K31/4545;A61K31/496;A61K31/506;A61K31/5377;A61K31/551;A61P1/04;A61P3/10;A61P5/14;A61P7/04;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P27/02;A61P27/16;A61P29/00;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D401/12;C07D401/14;C07D405/12;C07D413/12;C07D417/12 主分类号 C07D213/82
代理机构 代理人
主权项
地址